Baudax Bio logo
Baudax Bio BXRX

Quartalsbericht 2023-Q3
hinzugefügt 20.11.2023

report update icon

Baudax Bio Kurshistorie 2011-2026 | BXRX

Kurshistorie Jährlich Baudax Bio

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.35 6.51 46.5 293 - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
293 2.35 87.1

Kurshistorie anderer Aktien in der Pharmaeinzelhändler

Name Kurshistorie Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
18.2 - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
0.68 - - $ 866 M chinaChina
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
22 $ 20.7 -1.24 % $ 2.61 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
0.75 $ 0.84 7.59 % $ 4.58 M chinaChina
Biophytis SA Biophytis SA
BPTS
0.33 - -13.47 % $ 169 M franceFrance
Axsome Therapeutics Axsome Therapeutics
AXSM
174 $ 166.38 1.52 % $ 8.28 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
3.22 $ 3.82 5.82 % $ 1.14 B canadaCanada
Midatech Pharma plc Midatech Pharma plc
MTP
0.29 - -18.52 % $ 27.3 M britainBritain
Burford Capital Limited Burford Capital Limited
BUR
10.6 $ 8.73 3.44 % $ 1.37 B britainBritain
Capricor Therapeutics Capricor Therapeutics
CAPR
5.8 $ 26.86 -3.83 % $ 719 M usaUSA
Codexis Codexis
CDXS
3.97 $ 1.02 0.99 % $ 74.9 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.86 - - $ 86.2 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
1.27 $ 3.8 -2.06 % $ 116 M franceFrance
ARCA biopharma ARCA biopharma
ABIO
28.8 - 1052.0 % $ 415 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
0.77 - 2.71 % $ 14 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.04 - - $ 2.17 B usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
1.36 $ 3.13 -0.95 % $ 1.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
13.5 - -24.86 % $ 820 K usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
44.2 $ 41.6 -0.17 % $ 1.32 B usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
36.1 $ 35.97 0.76 % $ 3.74 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
24.9 $ 23.88 3.47 % $ 2.92 B usaUSA
Acasti Pharma Acasti Pharma
ACST
3.37 - 4.01 % $ 150 M canadaCanada
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
10.4 $ 8.35 -2.57 % $ 36.1 M usaUSA
Curis Curis
CRIS
2.1 $ 1.08 -5.26 % $ 6.81 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
43.7 $ 40.68 -1.02 % $ 3.83 B usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
1.96 $ 17.89 -2.03 % $ 859 M usaUSA
Champions Oncology Champions Oncology
CSBR
7.75 $ 6.07 2.71 % $ 82.9 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
3.6 $ 0.72 -2.3 % $ 4.84 M usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
0.41 $ 3.83 -10.09 % $ 244 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
19.3 - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
5.72 - 5.93 % $ 314 M canadaCanada
Daré Bioscience Daré Bioscience
DARE
2.89 $ 1.61 -5.29 % $ 13.7 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
6.5 $ 23.25 10.77 % $ 2.26 B franceFrance
AgeX Therapeutics AgeX Therapeutics
AGE
13 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.3 - - $ 26.5 M usaUSA
Precision BioSciences Precision BioSciences
DTIL
13 $ 4.33 3.1 % $ 16.6 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.17 - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
0.6 $ 3.34 0.3 % $ 1.2 M usaUSA
Dyadic International Dyadic International
DYAI
1.67 $ 0.77 -1.68 % $ 22.2 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
0.5 - - $ 7.46 M israelIsrael
Editas Medicine Editas Medicine
EDIT
2.02 $ 2.15 -2.27 % $ 177 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
1.9 $ 2.28 3.64 % $ 7.29 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
48.4 - - $ 3.67 B usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
28.1 $ 29.2 -3.41 % $ 1.69 B usaUSA
Advaxis Advaxis
ADXS
0.31 - -9.65 % $ 45.9 M usaUSA
Equillium Equillium
EQ
2.44 $ 1.92 5.49 % $ 66.7 M usaUSA